PASS Expects FDA’s Sunscreen Innovation Approach Will Surprise Capitol Hill
This article was originally published in The Tan Sheet
Executive Summary
The Public Access to Sunscreens coalition says FDA’s approach to reviewing sunscreen TEA applications is contrary to congressional intent in the Sunscreen Innovation Act and renders the process “virtually meaningless.” The discord largely stems from differing regulatory interpretations and unmet expectations.